Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
ACRV holding history
Acrivon Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRV overviewAll 13F holders of ACRVFull Q2 2026 holdings
- Shares (Q2 2026)
- 758,863
- Value
- $1.35M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 758,863 | $1.35M | <0.1% | +423+0.1% | Added | Holders |
| Q1 2026 | 758,440 | $1.05M | <0.1% | +124,271+19.6% | Added | Holders |
| Q4 2025 | 634,169 | $1.53M | <0.1% | +10,769+1.7% | Added | Holders |
| Q3 2025 | 623,400 | $1.13M | <0.1% | +114,105+22.4% | Added | Holders |
| Q2 2025 | 509,295 | $606.1K | <0.1% | +457,195+877.5% | Added | Holders |
| Q1 2025 | 52,100 | $105.8K | <0.1% | +2,700+5.5% | Added | Holders |
| Q4 2024 | 49,400 | $297.4K | <0.1% | +3,500+7.6% | Added | Holders |
| Q3 2024 | 45,900 | $321.3K | <0.1% | −8,600−15.8% | Reduced | Holders |
| Q2 2024 | 54,500 | $316.1K | <0.1% | −48,100−46.9% | Reduced | Holders |
| Q1 2024 | 102,600 | $734.0K | <0.1% | +102,600 | New | Holders |